Citation: Bmjl. Mannaerts et al., A RANDOMIZED 3-WAY CROSS-OVER STUDY IN HEALTHY PITUITARY-SUPPRESSED WOMEN TO COMPARE THE BIOAVAILABILITY OF HUMAN CHORIONIC-GONADOTROPIN (PREGNYL(R)) AFTER INTRAMUSCULAR AND SUBCUTANEOUS ADMINISTRATION, Human reproduction (Oxford. Print), 13(6), 1998, pp. 1461-1464
Citation: D. Dejong et al., HIGH-DOSE GONADOTROPIN-RELEASING-HORMONE ANTAGONIST (GANIRELIX) MAY PREVENT OVARIAN HYPERSTIMULATION SYNDROME CAUSED BY OVARIAN STIMULATIONFOR IN-VITRO FERTILIZATION, Human reproduction, 13(3), 1998, pp. 573-575
Authors:
OUT HJ
DRIESSEN SGAJ
MANNAERTS BMJL
BENNINK HJTC
Citation: Hj. Out et al., RECOMBINANT FOLLICLE-STIMULATING-HORMONE (FOLLITROPIN-BETA, PUREGON-ASTERISK) YIELDS HIGHER PREGNANCY RATES IN IN-VITRO FERTILIZATION THAN URINARY GONADOTROPINS, Fertility and sterility, 69(2), 1998, pp. 40-44
Authors:
OUT HJ
DRIESSEN SGAJ
MANNAERTS BMJL
BENNINK HJTC
Citation: Hj. Out et al., RECOMBINANT FOLLICLE-STIMULATING-HORMONE (FOLLITROPIN-BETA, PUREGON) YIELDS HIGHER PREGNANCY RATES IN IN-VITRO FERTILIZATION THAN URINARY GONADOTROPINS, Fertility and sterility, 68(1), 1997, pp. 138-142
Authors:
OUT HJ
MANNAERTS BMJL
DRIESSEN SGAJ
COELINGHBENNINK HJT
Citation: Hj. Out et al., A PROSPECTIVE, RANDOMIZED, ASSESSOR-BLIND, MULTICENTER STUDY COMPARING RECOMBINANT AND URINARY FOLLICLE-STIMULATING-HORMONE (PUREGON VERSUSMETRODIN) IN IN-VITRO FERTILIZATION, Human reproduction, 10(10), 1995, pp. 2534-2540
Authors:
SCHOOT DC
HARLIN J
SHOHAM Z
MANNAERTS BMJL
LAHLOU N
BOUCHARD P
BENNINK HJTC
FAUSER BCJM
Citation: Dc. Schoot et al., RECOMBINANT HUMAN FOLLICLE-STIMULATING-HORMONE AND OVARIAN RESPONSE IN GONADOTROPIN-DEFICIENT WOMEN, Human reproduction, 9(7), 1994, pp. 1237-1242